Avandia drug Canada-wide settlement reached

Monday, November 12, 2018 Medico Legal News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, ON, Nov. 12, 2018 /CNW/ - The Avandia drug class action lawsuit has reached a Canada-wide

settlement, Siskinds LLP announced today.

The settlement applies to Canadians who were prescribed the drug Avandia before November 15, 2018 and, if that person is deceased, to their spouse, children, grandchildren,

parents, grandparents and siblings (together "Class Members").

Compensation may be available to Class Members who suffered a heart attack, congestive heart failure, coronary artery bypass graft (CABG), and/ or coronary intervention stent placement.

Class Members who do not wish to participate in the lawsuit must opt out by January 15, 2019. Resources are available to Class Members on the official case website, www.avandiaclassaction.ca.

SOURCE Siskinds LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store